Maya Leabman
About Maya Leabman
Maya Leabman serves as the Director of Antibody PKPD at IgM Biosciences, where she has worked since 2019. She has a strong background in scientific research, having held various positions at Genentech and earned her Doctorate from the University of California, San Francisco.
Work at IGM Biosciences
Maya Leabman has held the position of Director, Antibody Pharmacokinetics and Pharmacodynamics (Pkpd) at IGM Biosciences since 2019. Her role involves overseeing the development and optimization of antibody therapies. IGM Biosciences is located in Mountain View, California, where Leabman has contributed to advancing the company's research and development efforts in antibody-based treatments.
Previous Experience at Genentech
Prior to her current role, Maya Leabman worked at Genentech for a total of eight years, where she progressed through various positions. She served as an Associate Scientist from 2004 to 2006, then as a Scientist from 2006 to 2013, and finally as a Senior Scientist from 2013 to 2014. During her tenure, she contributed to significant projects in the field of biotechnology and drug development.
Research Experience at UCSF
Before her time at Genentech, Maya Leabman worked as a Research Specialist at the University of California, San Francisco (UCSF) from 2002 to 2004. In this role, she engaged in research activities that supported the university's scientific initiatives and contributed to her foundational knowledge in the field.
Education and Expertise
Maya Leabman earned her Doctor of Philosophy degree from the University of California, San Francisco, completing her studies from 1997 to 2002. She also holds a Bachelor of Science degree in Chemical Engineering from the Massachusetts Institute of Technology, where she studied from 1993 to 1997. Her educational background provides her with a strong foundation in scientific research and engineering principles.